Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronika Buxhofer

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Acta Medica Austriaca. Supplement|January 1, 2003
[Introduction]W Hinterberger, Veronika Buxhofer, C Ausch
European Journal of Haematology|February 24, 2006
Bcr-abl positive blast crisis of chronic myeloid leukemia emerging in a case of metastatic colorectal cancer 3 months after completion of an 8-month course of cetuximab and irinotecanVeronika Buxhofer-Ausch, Margareta Hinterberger-Fischer, Wolfgang Hinterberger
Experimental and Therapeutic Medicine|November 9, 2012
Circulating cytokeratin 18 fragments and activation of dormant tumor cells in bone marrow of cancer patientsChristoph Ausch, Veronika Buxhofer-Ausch, Ulrike Olszewski, et al.
Acta Medica Austriaca. Supplement|January 1, 2003
[Immunocytochemical and molecular detection of minimal residual disease in blood and bone marrow in colorectal cancer]Veronika Buxhofer, C Ausch, E Ogris, et al.
Leukemia Research|February 28, 2012
Successful treatment sequence incorporating bevacizumab for therapy of polyneuropathy in two patients with POEMS syndromeVeronika Buxhofer-Ausch, Bettina Gisslinger, Gerhard Stangl, et al.
European Journal of Haematology|November 21, 2008
Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosisVeronika Buxhofer-Ausch, Heinz Gisslinger, Tiina Berg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 13, 2020
Successful kidney transplantation in a patient with pre-existing chronic myeloid leukemia treated with imatinibUrsula Thiem, Veronika Buxhofer-Ausch, Wolfgang Kranewitter, et al.
Blood|March 31, 2011
Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classificationJürgen Thiele, Hans Michael Kvasnicka, Leonhard Müllauer, et al.
Journal of Cancer Research and Clinical Oncology|March 6, 2023
TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancerIrene Strassl, Armin Windhager, Sigrid Machherndl-Spandl, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 4, 2009
Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patientsChristoph Ausch, Veronika Buxhofer-Ausch, Ulrike Olszewski, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Acta Medica Austriaca. Supplement|January 1, 2003
[Introduction]W Hinterberger, Veronika Buxhofer, C Ausch
European Journal of Haematology|February 24, 2006
Bcr-abl positive blast crisis of chronic myeloid leukemia emerging in a case of metastatic colorectal cancer 3 months after completion of an 8-month course of cetuximab and irinotecanVeronika Buxhofer-Ausch, Margareta Hinterberger-Fischer, Wolfgang Hinterberger
Experimental and Therapeutic Medicine|November 9, 2012
Circulating cytokeratin 18 fragments and activation of dormant tumor cells in bone marrow of cancer patientsChristoph Ausch, Veronika Buxhofer-Ausch, Ulrike Olszewski, et al.
Acta Medica Austriaca. Supplement|January 1, 2003
[Immunocytochemical and molecular detection of minimal residual disease in blood and bone marrow in colorectal cancer]Veronika Buxhofer, C Ausch, E Ogris, et al.
Leukemia Research|February 28, 2012
Successful treatment sequence incorporating bevacizumab for therapy of polyneuropathy in two patients with POEMS syndromeVeronika Buxhofer-Ausch, Bettina Gisslinger, Gerhard Stangl, et al.
European Journal of Haematology|November 21, 2008
Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosisVeronika Buxhofer-Ausch, Heinz Gisslinger, Tiina Berg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 13, 2020
Successful kidney transplantation in a patient with pre-existing chronic myeloid leukemia treated with imatinibUrsula Thiem, Veronika Buxhofer-Ausch, Wolfgang Kranewitter, et al.
Blood|March 31, 2011
Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classificationJürgen Thiele, Hans Michael Kvasnicka, Leonhard Müllauer, et al.
Journal of Cancer Research and Clinical Oncology|March 6, 2023
TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancerIrene Strassl, Armin Windhager, Sigrid Machherndl-Spandl, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 4, 2009
Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patientsChristoph Ausch, Veronika Buxhofer-Ausch, Ulrike Olszewski, et al.
Pageof 8